sibenadet has been researched along with 1-methyl-d-lysergic acid butanolamide in 1 studies
| Studies (sibenadet) | Trials (sibenadet) | Recent Studies (post-2010) (sibenadet) | Studies (1-methyl-d-lysergic acid butanolamide) | Trials (1-methyl-d-lysergic acid butanolamide) | Recent Studies (post-2010) (1-methyl-d-lysergic acid butanolamide) |
|---|---|---|---|---|---|
| 27 | 7 | 6 | 29 | 0 | 9 |
| Protein | Taxonomy | sibenadet (IC50) | 1-methyl-d-lysergic acid butanolamide (IC50) |
|---|---|---|---|
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.912 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
1 other study(ies) available for sibenadet and 1-methyl-d-lysergic acid butanolamide
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |